Search - Prime Therapeutics - Portal

388 Results for GLP-1 Pipeline Update

USA Today: These 15 metro areas saw biggest jumps in Ozempic use. They might not be where you expect.

USA Today

PA Sub-Categories: GLP-1 Prime Article: In the News
Reuters: Adherence to weight-loss drugs is far higher with Wegovy than older medicines

Reuters

PA Sub-Categories: GLP-1 Prime Article: In the News
Insider: A new analysis finds most patients don't stay on weight-loss drugs like Wegovy longer than one year

Insider

PA Sub-Categories: GLP-1 Prime Article: In the News
CNBC: Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all

CNBC

PA Sub-Categories: GLP-1 Prime Article: In the News
Formulary Watch: Real-World Study Finds Low Patient Adherence for Weight Loss Drugs

Formulary Watch

PA Sub-Categories: GLP-1 Prime Article: In the News
Star Tribune: Study: Trendy weight-loss drugs could be a waste for Minnesotans, health plans

Star Tribune

PA Sub-Categories: GLP-1 Prime Article: In the News
Business Insider: Inside your company's struggle over whether to pay for hot, new weight-loss drugs

Business Insider

PA Sub-Categories: GLP-1 Prime Article: In the News
Endpoint News: Almost all patients quit weight loss shots within two years, analysis finds

Endpoint News

PA Sub-Categories: GLP-1 Prime Article: In the News

Page 1
- Page 2
- Page 3
- Page 4
- Page 5
- Page 6
- Page 7
- Page 8
- Page 9
- Page 10
- Page 11
- Page 12
- Page 13
- Page 14
- Page 15
- Page 16
- Page 17
Page 18
Page 19
Page 20
- Page 21
- Page 22
- Page 23
- Page 24
- Page 25
- Page 26
- Page 27
- Page 28
- Page 29
- Page 30
- Page 31
- Page 32
- Page 33
- Page 34
- Page 35
- Page 36
- Page 37
- Page 38
- Page 39
- Page 40
Page 49

Login Portals

Compliance / Legal

Company

© 2025 Prime Therapeutics LLC